Skip to main content
SpringerLink
Log in

Osteoporosis and Hip Fractures

  • Chapter
Diagnosis and Management of Hip Disease

  • 1118 Accesses

Abstract

Hip fractures due to osteoporosis have become a major public health concern impacting both healthcare expenditure and patient outcomes. Despite established interventions, 1 year patient mortality is approximately 25 %. A majority of patients who experience a hip fracture suffer residual functional impairments and are at greater risk of subsequent fracture. This chapter will discuss the prevention of osteoporotic hip fractures through the use of a metabolic bone evaluation in order to reduce costs, morbidity, and mortality. In addition, this chapter will also review different types of fragility fractures, which are a major consequence of osteoporosis. Both surgical and pharmacological strategies for the treatment of osteoporotic fragility fractures of both the hip and pelvis are also reviewed in this chapter. A brief introduction of the dynamics of a fracture liaison service will be provided in order to establish a logarithm for anti-osteoporotic care. Overall, this chapter will discuss osteoporosis management, fragility fracture risk factors, and interventions to treat and prevent osteoporosis-related fragility fractures.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

BMI:

Body mass index

BMP:

Basic metabolic protein

CTX:

C-terminal telopeptide

DHS:

Dynamic hip screw

DXA:

Dual energy X-ray

FRAX:

Fracture Risk Assessment Tool

IM:

Intramedullary

IMN:

Intramedullary implant

NTX:

N-terminal telopeptide

P1NP:

Procollagen type 1 N propeptide

PTH:

Parathyroid hormone

qCT:

Quantitative computed tomography

RANKL:

Receptor activator of nuclear factor kappa-B ligand

THR:

Total hip replacement

TSH:

Thyroid stimulating hormone

References

  1. Burge R, Dawson-Hughes B, Solomon DH, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res. 2007;22(3):465–75.

    PubMed  Google Scholar 

  2. Center JR, Biliuc D, Nguyen TV, et al. Risk of subsequent fracture after low-trauma fracture in men and women. JAMA. 2007;297(4):387–94.

    CAS  PubMed  Google Scholar 

  3. Biliuc D, Nguyen ND, Milch VE, et al. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA. 2009;301(5):513–21.

    Google Scholar 

  4. “osteoporosis.” Merriam-Webster.com. (2014). http://www.merriam-webster.com/dictionary/osteoporosis. 9 September 2014.

  5. National Osteoporosis Foundation. Clinician’s guide to prevention and treatment of osteoporosis. Washington, DC: National Osteoporosis Foundation; 2014.

    Google Scholar 

  6. Alexandru D, So W. Evaluation and management of vertebral compression fractures. Perm J. 2012;16(4):46–51.

    PubMed Central  PubMed  Google Scholar 

  7. Kanis J. Diagnosis of osteoporosis and assessment of fracture risk. Lancet. 2002;359:1929–36.

    PubMed  Google Scholar 

  8. Blake GM, Fogelman I. The role of DXA bone density scans in the diagnosis and treatment of osteoporosis. Postgrad Med J. 2007;83(982):509–17.

    PubMed Central  PubMed  Google Scholar 

  9. Kanis JA, Johnell O, Oden A, et al. Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int. 2001;12:989–95.

    CAS  PubMed  Google Scholar 

  10. Kanis JA, Oden A, Johnell O, et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fracture in men and women. Osteoporos Int. 2007;18(8):1033–46.

    CAS  PubMed  Google Scholar 

  11. Sunyecz JA. The use of calcium and vitamin D in the management of osteoporosis. Ther Clin Risk Manag. 2008;4(4):827–36.

    CAS  PubMed Central  PubMed  Google Scholar 

  12. Keene GS, Parker MJ, Pryor GA. Mortality and morbidity after hip fractures. BMJ. 1993;307(6914):1248–50.

    CAS  PubMed Central  PubMed  Google Scholar 

  13. Dahl E. Mortality and life expectancy after hip fractures. Acta Orthop Scand. 1980;51(1):163–70.

    CAS  PubMed  Google Scholar 

  14. Koval KJ, Aharonoff GB, Rokito AS, Lyon T, Zuckerman JD. Patients with femoral neck and intertrochanteric fractures. Are they the same? Clin Orthop Relat Res. 1996;330:166–72.

    PubMed  Google Scholar 

  15. Cooper CG, Campion G, Melton 3rd LJ. Hip fractures in the elderly: a world-wide projection. Osteoporos Int. 1992;2(6):285–9.

    CAS  PubMed  Google Scholar 

  16. Jalovaara P, Virkkunen H. Quality of life after primary hemiarthroplasty for femoral neck fracture. 6-year follow-up of 185 patients. Acta Orthop Scand. 1991;62(3):208–17.

    CAS  PubMed  Google Scholar 

  17. Jacobsen SJ, Goldberg J, Miles TP, Brody JA, Stiers W, Rimm AA. Race and sex differences in mortality following fracture of the hip. Am J Public Health. 1992;82(8):1147–50.

    CAS  PubMed Central  PubMed  Google Scholar 

  18. Lu-Yao GL, Baron JA, Barrett JA, Fisher ES. Treatment and survival among elderly Americans with hip fractures: a population-based study. Am J Public Health. 1994;84(8):1287–91.

    CAS  PubMed Central  PubMed  Google Scholar 

  19. Magaziner J, Simonsick EM, Kashner TM, Hebel JR, Kenzora JE. Survival experience of aged hip fracture patients. Am J Public Health. 1989;79(3):274–8.

    CAS  PubMed Central  PubMed  Google Scholar 

  20. White BL, Fisher WD, Laurin CA. Rate of mortality for elderly patients after fracture of the hip in the 1980’s. J Bone Joint Surg Am. 1987;69(9):1335–40.

    CAS  PubMed  Google Scholar 

  21. Willig R, Keinanen-Kiukaaniemi S, Jalovaaran P. Mortality and quality of life after trochanteric hip fracture. Public Health. 2001;115(5):323–7.

    CAS  PubMed  Google Scholar 

  22. Keene JS, Anderson CA. Hip fractures in the elderly. Discharge predictions with a functional rating scale. JAMA. 1982;248(5):564–7.

    CAS  PubMed  Google Scholar 

  23. Capeci CM, Tejwani NC. Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy. J Bone Joint Surg Am. 2009;91(11):2556–61.

    PubMed  Google Scholar 

  24. Goh SK, Yang KY, Koh JS, Wong MK, Chua SY, Chua DT, et al. Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution. J Bone Joint Surg Br. 2007;89(3):349–53.

    PubMed  Google Scholar 

  25. Der Schenkelhalsbruch FP. Ein mechanisches problem. Beilagheft Z. Orthop. Chir. Stuttgart, Enke; 1935. p. 64.

    Google Scholar 

  26. Garden RS. Stability and union in subcapital fractures of the femur. J Bone Joint Surg Br. 1964;46:630–47.

    CAS  PubMed  Google Scholar 

  27. Keating JF, Grant A, Masson M, Scott NW, Forbes JF. Randomized comparison of reduction and fixation, bipolar hemiarthroplasty, and total hip arthroplasty. Treatment of displaced intracapsular hip fractures in healthy older patients. J Bone Joint Surg Am. 2006;88(2):249–60.

    CAS  PubMed  Google Scholar 

  28. Tidermark J, Zethraeus N, Svensson O, Tornkvist H, Ponzer S. Quality of life related to fracture displacement among elderly patients with femoral neck fractures treated with internal fixation. J Orthop Trauma. 2002;16(1):34–8.

    PubMed  Google Scholar 

  29. Jain R, Koo M, Kreder HJ, Schemitsch EH, Davey JR, Mahomed NN. Comparison of early and delayed fixation of subcapital hip fractures in patients sixty years of age or less. J Bone Joint Surg Am. 2002;84-A(9):1605–12.

    PubMed  Google Scholar 

  30. Booth KC, Donaldson TK, Dai QG. Femoral neck fracture fixation: a biomechanical study of two cannulated screw placement techniques. Orthopedics. 1998;21(11):1173–6.

    CAS  PubMed  Google Scholar 

  31. Gurusamy K, Parker MJ, Rowlands TK. The complications of displaced intracapsular fractures of the hip: the effect of screw positioning and angulation on fracture healing. J Bone Joint Surg Br. 2005;87(5):632–4.

    CAS  PubMed  Google Scholar 

  32. Lindequist S, Tornkvist H. Quality of reduction and cortical screw support in femoral neck fractures. An analysis of 72 fractures with a new computerized measuring method. J Orthop Trauma. 1995;9(3):215–21.

    CAS  PubMed  Google Scholar 

  33. Zlowodzki M, Brink O, Switzer J, Wingerter S, Woodall Jr J, Petrisor BA, et al. The effect of shortening and varus collapse of the femoral neck on function after fixation of intracapsular fracture of the hip: a multi-centre cohort study. J Bone Joint Surg Br. 2008;90(11):1487–94.

    CAS  PubMed  Google Scholar 

  34. Liporace F, Gaines R, Collinge C, Haidukewych GJ. Results of internal fixation of Pauwels type-3 vertical femoral neck fractures. J Bone Joint Surg Am. 2008;90(8):1654–9.

    PubMed  Google Scholar 

  35. Parker MJ, Blundell C. Choice of implant for internal fixation of femoral neck fractures. Meta-analysis of 25 randomised trials including 4,925 patients. Acta Orthop Scand. 1998;69(2):138–43.

    CAS  PubMed  Google Scholar 

  36. Boraiah S, Paul O, Hammoud S, Gardner MJ, Helfet DL, Lorich DG. Predictable healing of femoral neck fractures treated with intraoperative compression and length-stable implants. J Trauma. 2010;69(1):142–7.

    PubMed  Google Scholar 

  37. Parker MJ, Stockton G. Internal fixation implants for intracapsular proximal femoral fractures in adults. Cochrane Database Syst Rev. 2001;4:CD001467.

    PubMed  Google Scholar 

  38. Lee YK, Ha YC, Koo KH. Teriparatide, a nonsurgical solution for femoral nonunion? A report of three cases. Osteoporos Int. 2012;23(12):2897–900.

    PubMed  Google Scholar 

  39. Yu CT, Wu JK, Chang CC, Chen CL, Wei JC. Early callus formation in human hip fracture treated with internal fixation and teriparatide. J Rheumatol. 2008;35(10):2082–3.

    PubMed  Google Scholar 

  40. Zahid M, Bin Sabir A, Asif N, Julfigar M, Khan AQ, Ahmad S, et al. Fixation using cannulated screws and fibular strut grafts for fresh femoral neck fractures with posterior comminution. J Orthop Surg (Hong Kong). 2012;20(2):191–5.

    Google Scholar 

  41. Gao H, Liu Z, Xing D, Gong M. Which is the best alternative for displaced femoral neck fractures in the elderly? A meta-analysis. Clin Orthop Relat Res. 2012;470(6):1782–91.

    PubMed Central  PubMed  Google Scholar 

  42. Kannan A, Kancherla R, McMahon S, Hawdon G, Soral A, Malhotra R. Arthroplasty options in femoral-neck fracture: answers from the national registries. Int Orthop. 2012;36(1):1–8.

    PubMed Central  PubMed  Google Scholar 

  43. Blomfeldt R, Tornkvist H, Eriksson K, Sodergvist A, Ponzer S, Tidermark J. A randomised controlled trial comparing bipolar hemiarthroplasty with total hip replacement for displaced intracapsular fractures of the femoral neck in elderly patients. J Bone Joint Surg Br. 2007;89(2):160–5.

    CAS  PubMed  Google Scholar 

  44. Tsukamoto Y, Mabuchi K, Futami T, Kubotera D. Motion of the bipolar hip prosthesis components. Friction studied in cadavers. Acta Orthop Scand. 1992;63(6):648–52.

    CAS  PubMed  Google Scholar 

  45. Devas M, Hinves B. Prevention of acetabular erosion after hemiarthroplasty for fractured neck of femur. J Bone Joint Surg Br. 1983;65(5):548–51.

    CAS  PubMed  Google Scholar 

  46. Lausten GS, Vedel P, Nielsen PM. Fractures of the femoral neck treated with a bipolar endoprosthesis. Clin Orthop Relat Res. 1987;218:63–7.

    PubMed  Google Scholar 

  47. Ong BC, Maurer SG, Aharonoff GB, Zuckerman JD, Koval KJ. Unipolar versus bipolar hemiarthroplasty: functional outcome after femoral neck fracture at a minimum of thirty-six months of follow-up. J Orthop Trauma. 2002;16(5):317–22.

    PubMed  Google Scholar 

  48. Cornell CN, Levine D, O’Doherty J, Lyden J. Unipolar versus bipolar hemiarthroplasty for the treatment of femoral neck fractures in the elderly. Clin Orthop Relat Res. 1998;348:67–71.

    PubMed  Google Scholar 

  49. Avery PP, Baker RP, Walton MJ, Rooker JC, Squires B, Gargan MF, et al. Total hip replacement and hemiarthroplasty in mobile, independent patients with a displaced intracapsular fracture of the femoral neck: a seven- to ten-year follow-up report of a prospective randomised controlled trial. J Bone Joint Surg Br. 2011;93(8):1045–8.

    CAS  PubMed  Google Scholar 

  50. Gregory RJ, Wood DJ, Stevens J. Treatment of displaced subcapital femoral fractures with total hip replacement. Injury. 1992;23(3):168–70.

    CAS  PubMed  Google Scholar 

  51. Noble PC, Durrani SK, Usrey MM, Mathis KB, Bardakos NV. Constrained cups appear incapable of meeting the demands of revision THA. Clin Orthop Relat Res. 2012;470(7):1907–16.

    PubMed Central  PubMed  Google Scholar 

  52. Fabry C, Kaehler M, Herrmann S, Woernle C, Bader R. Dynamic behavior of tripolar hip endoprostheses under physiological conditions and their effect on stability. Med Eng Phys. 2014;36(1):65–71.

    PubMed  Google Scholar 

  53. Costain DJ, Whitehouse SL, Pratt NL, Graves SE, Ryan P, Crawford RW. Perioperative mortality after hemiarthroplasty related to fixation method. Acta Orthop. 2011;82(3):275–81.

    PubMed Central  PubMed  Google Scholar 

  54. Khan RJ, MacDowell A, Crossman P, Keene GS. Cemented or uncemented hemiarthroplasty for displaced intracapsular fractures of the hip–a systematic review. Injury. 2002;33(1):13–7.

    CAS  PubMed  Google Scholar 

  55. Jameson SS, Kyle J, Baker PN, Mason J, Deehan DJ, McMurtry IA, et al. Patient and implant survival following 4323 total hip replacements for acute femoral neck fracture: a retrospective cohort study using National Joint Registry data. J Bone Joint Surg Br. 2012;94(11):1557–66.

    CAS  PubMed  Google Scholar 

  56. Viberg B, Overgaard S, Lauritsen J, Ovesen O. Lower reoperation rate for cemented hemiarthroplasty than for uncemented hemiarthroplasty and internal fixation following femoral neck fracture: 12- to 19-year follow-up of patients aged 75 years or more. Acta Orthop. 2013;84(3):254–9.

    PubMed Central  PubMed  Google Scholar 

  57. Baltzer AW, Ostapczuk MS, Stosch D, Granrath M. The use of recombinant human bone morphogenetic protein-2 for the treatment of a delayed union following femoral neck open-wedge osteotomy. Orthop Rev (Pavia). 2012;4(1):e4.

    Google Scholar 

  58. Evans EM. The treatment of trochanteric fractures of the femur. J Bone Joint Surg Br. 1949;31B(2):190–203.

    CAS  PubMed  Google Scholar 

  59. Koval KJ, Zuckerman JD. Intertrochanteric fractures. In: Bucholz RW, Heckman JD, editors. Rockwood and Green’s fractures in adults. Philadelphia: Lippincott Williams and Wilkins; 2001. p. 1635–63.

    Google Scholar 

  60. Zain Elabdien BS, Olerud S, Karlstrom G. The influence of age on the morphology of trochanteric fracture. Arch Orthop Trauma Surg. 1984;103(3):156–61.

    CAS  PubMed  Google Scholar 

  61. Haidukewych GJ, Israel TA, Berry DJ. Reverse obliquity fractures of the intertrochanteric region of the femur. J Bone Joint Surg Am. 2001;83-A(5):643–50.

    CAS  PubMed  Google Scholar 

  62. Medoff RJ, Maes K. A new device for the fixation of unstable pertrochanteric fractures of the hip. J Bone Joint Surg Am. 1991;73(8):1192–9.

    CAS  PubMed  Google Scholar 

  63. Baumgaertner MR, Curtin SL, Lindskog DM, Keggi JM. The value of the tip-apex distance in predicting failure of fixation of peritrochanteric fractures of the hip. J Bone Joint Surg Am. 1995;77(7):1058–64.

    CAS  PubMed  Google Scholar 

  64. Baumgaertner MR, Solberg BD. Awareness of tip-apex distance reduces failure of fixation of trochanteric fractures of the hip. J Bone Joint Surg Br. 1997;79(6):969–71.

    CAS  PubMed  Google Scholar 

  65. Zirngibl B, Biber R, Bail HJ. How to prevent cut-out and cut-through in biaxial proximal femoral nails: is there anything beyond lag screw positioning and tip-apex distance? Int Orthop. 2013;37(7):1363–8.

    PubMed Central  PubMed  Google Scholar 

  66. Geller JA, Saifi C, Morrison TA. Tip-apex distance of intramedullary devices as a predictor of cut-out failure in the treatment of peritrochanteric elderly hip fractures. Int Orthop. 2010;34(5):719–22.

    PubMed Central  PubMed  Google Scholar 

  67. Parker MJ, Handoll HH. Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults. Cochrane Database Syst Rev. 2010;9:CD000093.

    PubMed  Google Scholar 

  68. Saudan M, Lubbeke A, Sadowski C, Riand N, Stern R, Hoffmeyer P. Pertrochanteric fractures: is there an advantage to an intramedullary nail? A randomized, prospective study of 206 patients comparing the dynamic hip screw and proximal femoral nail. J Orthop Trauma. 2002;16(6):386–93.

    PubMed  Google Scholar 

  69. Hardy DC, Descamps PY, Krallis P, Fabeck L, Smets P, Bertens CL, et al. Use of an intramedullary hip-screw compared with a compression hip-screw with a plate for intertrochanteric femoral fractures. A prospective, randomized study of one hundred patients. J Bone Joint Surg Am. 1998;80(5):618–30.

    CAS  PubMed  Google Scholar 

  70. Utrilla AL, Reig JS, Munoz FM, Tufanisco CB. Trochanteric gamma nail and compression hip screw for trochanteric fractures: a randomized, prospective, comparative study in 210 elderly patients with a new design of the gamma nail. J Orthop Trauma. 2005;19(4):229–33.

    PubMed  Google Scholar 

  71. Anglen JO, Weinstein JN. American Board of Orthopaedic Surgery Research Committee. Nail or plate fixation of intertrochanteric hip fractures: changing pattern of practice. A review of the American Board of Orthopaedic Surgery Database. J Bone Joint Surg Am. 2008;90(4):700–7.

    PubMed  Google Scholar 

  72. Boone C, Carlberg KN, Koueiter DM, Baker KC, Sadowski J, Wiater PJ, et al. Short versus long intramedullary nails for treatment of intertrochanteric femur fractures (OTA 31-A1 and A2). J Orthop Trauma. 2014;28(5):e96–100.

    PubMed  Google Scholar 

  73. Hou Z, Bowen TR, Irgit KS, Matzko ME, Andreychik CM, Horwitz DS, et al. Treatment of pertrochanteric fractures (OTA 31-A1 and A2): long versus short cephalomedullary nailing. J Orthop Trauma. 2013;27(6):318–24.

    PubMed  Google Scholar 

  74. Kleweno C, Morgan J, Redshaw J, Harris M, Rodriguez E, Zurakowski D, et al. Short versus long cephalomedullary nails for the treatment of intertrochanteric hip fractures in patients older than 65 years. J Orthop Trauma. 2014;28(7):391–7.

    PubMed  Google Scholar 

  75. Norris R, Bhattacharjee D, Parker MJ. Occurrence of secondary fracture around intramedullary nails used for trochanteric hip fractures: a systematic review of 13,568 patients. Injury. 2012;43(6):706–11.

    PubMed  Google Scholar 

  76. Yamamoto T. Subchondral insufficiency fractures of the femoral head. Clin Orthop Surg. 2012;4(3):173–80.

    PubMed Central  PubMed  Google Scholar 

  77. Ikemura S, Yamamoto T, Motomura G, Nakashima Y, Mawatari T, Iwamoto Y. MRI evaluation of collapsed femoral heads in patients 60 years old or older: Differentiation of subchondral insufficiency fracture from osteonecrosis of the femoral head. AJR Am J Roentgenol. 2010;195(1):W63–8.

    PubMed  Google Scholar 

  78. Ikemura S, Yamamoto T, Motomura G, Nakashima Y, Mawatari T, Iwamoto Y. The utility of clinical features for distinguishing subchondral insufficiency fracture from osteonecrosis of the femoral head. Arch Orthop Trauma Surg. 2013;133(12):1623–7.

    PubMed  Google Scholar 

  79. Iwasaki K, Yamamoto T, Motomura G, Ikemura S, Yamaguchi R, Iwamoto Y. Radiologic measurements associated with the prognosis and need for surgery in patients with subchondral insufficiency fractures of the femoral head. AJR Am J Roentgenol. 2013;201(1):W97–103.

    PubMed  Google Scholar 

  80. Miyanishi K, Ishihara K, Jingushi S, Torisu T. Risk factors leading to total hip arthroplasty in patients with subchondral insufficiency fractures of the femoral head. J Orthop Surg (Hong Kong). 2010;18(3):271–5.

    Google Scholar 

  81. Leslie MP, Baumgaertner MR. Osteoporotic pelvic ring injuries. Orthop Clin North Am. 2013;44(2):217–24.

    PubMed  Google Scholar 

  82. Wu CC, Wei JC, Hsieh CP, Yu CT. Enhanced healing of sacral and pubic insufficiency fractures by teriparatide. J Rheumatol. 2012;39(6):1306–7.

    CAS  PubMed  Google Scholar 

  83. Jorgensen NR, Schwarz P. Effects of anti-osteoporosis medications on fracture healing. Curr Osteoporos Rep. 2011;9(3):149–55.

    PubMed  Google Scholar 

  84. Eriksen EF, Lyles KW, Colon-Emeric CS, Pieper CF, Magaziner JS, Adachi JD, et al. Antifracture efficacy and reduction of mortality in relation to timing of the first dose of zoledronic acid after hip fracture. J Bone Miner Res. 2009;24(7):1308–13.

    CAS  PubMed  Google Scholar 

  85. Colon-Emeric C, Nordsletten L, Olson S, Major N, Boonen S, Haentjens P, et al. Association between timing of zoledronic acid infusion and hip fracture healing. Osteoporos Int. 2011;22(8):2329–36.

    CAS  PubMed  Google Scholar 

  86. Schindler OS, Watura R, Cobby M. Sacral insufficiency fractures. J Orthop Surg (Hong Kong). 2007;15(3):339–46.

    CAS  Google Scholar 

  87. Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med. 1992;327(23):1637–42.

    CAS  PubMed  Google Scholar 

  88. Heller HJ, Greer LG, Haynes SD, Poindexter JR, Pak CY. Pharmacokinetic and pharmacodynamics comparison of two calcium supplements in postmenopausal women. J Clin Pharmacol. 2000;40(11):1237–44.

    CAS  PubMed  Google Scholar 

  89. Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA. 2006;296(24):2947–53.

    CAS  PubMed  Google Scholar 

  90. Steingrimsdottir L, Gunnarsson O, Indridason OS, et al. Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA. 2005;294(19):2336–41.

    CAS  PubMed  Google Scholar 

  91. Adler RA. Laboratory testing for secondary osteoporosis evaluation. Clin Biochem. 2012;45(12):894–900.

    CAS  PubMed  Google Scholar 

  92. Adams JS, Song CF, Kantorovich V. Rapid recovery of bone mass in hypercalciuric, osteoporotic men treated with hydrochlorothiazide. Ann Intern Med. 1999;130(8):658–60.

    CAS  PubMed  Google Scholar 

  93. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, Staehelin HB, Bazemore MG, Zee RY, et al. Effect of Vitamin D on falls: a meta-analysis. JAMA. 2004;291(16):1999–2006.

    CAS  PubMed  Google Scholar 

  94. Russell RG. Bisphosphonates: the first 40 years. Bone. 2011;49:2–19.

    CAS  PubMed  Google Scholar 

  95. Chapurlat RD, Palermo L, Ramsay P, Cummings SR. Risk of fracture among women who lose bone density during treatment with alendronate. The Fracture intervention trial. Osteoporos Int. 2005;16(7):842–8.

    CAS  PubMed  Google Scholar 

  96. Lyles KW, Colon-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, et al. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med. 2007;357(18):1799–809.

    CAS  PubMed  Google Scholar 

  97. Moen MD, Keam SJ. Denosumab: a review of its use in the treatment of postmenopausal osteoporosis. Drugs Aging. 2011;28(1):63–82.

    CAS  PubMed  Google Scholar 

  98. Gerstenfeld LC, Sacks DJ, Pelis M, Mason ZD, Graves DT, Barrero M, et al. Comparison of effects of the bisphosphonate alendronate versus the RANKL inhibitor denosumab on murine fracture healing. J Bone Miner Res. 2009;24(2):196–208.

    CAS  PubMed  Google Scholar 

  99. Adami S, Libanati C, Boonen S, Cummings SR, Ho PR, Wang A, et al. Denosumab treatment in postmenopausal women with osteoporosis does not interfere with fracture-healing: results from the FREEDOM trial. J Bone Joint Surg Am. 2012;94:2113–9.

    PubMed  Google Scholar 

  100. Aspenberg P, Genant HK, Johansson T, Nino AJ, See K, Krohn K, et al. Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures. J Bone Miner Res. 2010;25(2):404–14.

    CAS  PubMed  Google Scholar 

  101. Peichl P, Holzer LA, Maier R, Holzer G. Parathyroid hormone 1-84 accelerates fracture-healing in pubic bones of elderly osteoporotic women. J Bone Joint Surg Am. 2011;93(17):1583–7.

    PubMed  Google Scholar 

  102. Ohtori S, Inoue G, Orita S, et al. Teriparatide accelerates lumbar posterolateral fusion in women with postmenopausal osteoporosis. Spine. 2012;37(23):E1464–8.

    PubMed  Google Scholar 

  103. Ohtori S, Inoue G, Orita S, et al. Comparison of teriparatide and bisphosphonate treatment to reduce pedicle screw loosening after lumbar spinal fusion surgery in postmenopausal women with osteoporosis from a bone quality perspective. Spine. 2013;38(8):E487–92.

    PubMed  Google Scholar 

  104. Chiang CY, Zebaze RM, Ghasem-Zadeh A, et al. Teriparatide improves bone quality and healing of atypical femoral fractures associated with bisphosphonate therapy. Bone. 2013;52(1):360–5.

    CAS  PubMed  Google Scholar 

  105. Kang JH, Keller JJ, Lin HC. Bisphosphonates reduced the risk of acute myocardial infarction: a 2-year follow-up study. Osteoporos Int. 2013;24(1):271–7.

    CAS  PubMed  Google Scholar 

  106. Shane E, Burr D, Eberling PR, Abrahamsen B, Adler RA, Brown TD, et al. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2010;25(11):2267–94.

    PubMed  Google Scholar 

  107. Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD, Cheung AM, et al. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the american society for bone and mineral research. J Bone Miner Res. 2014;29(1):1–23.

    PubMed  Google Scholar 

  108. Thompson RN, Armstrong CL, Heyburn G. Bilateral atypical femoral fractures in a patient prescribed denosumab – a case report. Bone. 2014;61:44–7.

    PubMed  Google Scholar 

  109. Schilcher J, Aspenberg P. Atypical fracture of the femur in a patient using denosumab–a case report. Acta Orthop. 2014;85(1):6–7.

    PubMed Central  PubMed  Google Scholar 

  110. Drampalos E, Skarpas G, Barbounakis N, Michos I. Atypical femoral fractures bilaterally in a patient receiving denosumab. Acta Orthop. 2014;85(1):3–5.

    PubMed Central  PubMed  Google Scholar 

  111. Lo JC, Huang SY, Lee GA, Khandelwal S, Provus J, Ettinger B, et al. Clinical correlates of atypical femoral fracture. Bone. 2012;51(1):181–4.

    PubMed  Google Scholar 

  112. Kwek EB, Goh SK, Koh JS, Png MA, Howe TS. An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy? Injury. 2008;39(2):224–31.

    PubMed  Google Scholar 

  113. Allison MB, Markman L, Rosenberg Z, Viera RL, Babb J, Tejwani N, et al. Atypical incomplete femoral fractures in asymptomatic patients on long term bisphosphonate therapy. Bone. 2013;55(1):113–8.

    CAS  PubMed  Google Scholar 

  114. Prasarn ML, Ahn J, Helfet DL, Lane JM, Lorich DG. Bisphosphonate-associated femur fractures have high complication rates with operative fixation. Clin Orthop Relat Res. 2012;470(8):2295–301.

    PubMed Central  PubMed  Google Scholar 

  115. Edwards BJ, Bunta AD, Lane J, Odvina C, Rao DS, Raisch DW, et al. Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project. J Bone Joint Surg Am. 2013;95(4):297–307.

    PubMed Central  PubMed  Google Scholar 

  116. Eisman JA, Bogoch ER, Dell R, et al. Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention. J Bone Miner Res. 2012;27(10):2039–46.

    PubMed  Google Scholar 

  117. Mitchell PJ. Best practices in secondary fracture prevention: fracture liaison services. Curr Osteoporos Rep. 2013;11(1):52–60.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Orthopedic Surgery, Hospital for Special Surgery, 535 East 70th Street, New York, 10021, NY, USA

    Deniz Olgun MD, Arianna L. Gianakos BS, Jonathan Jo BS, Libi Galmer DO & Joseph M. Lane MD

Authors
  1. Deniz Olgun MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arianna L. Gianakos BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jonathan Jo BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Libi Galmer DO
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Joseph M. Lane MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Arianna L. Gianakos BS .

Editor information

Editors and Affiliations

  1. Department of Orthopedics, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA

    Roy K. Aaron

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Olgun, D., Gianakos, A.L., Jo, J., Galmer, L., Lane, J.M. (2015). Osteoporosis and Hip Fractures. In: Aaron, R. (eds) Diagnosis and Management of Hip Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-19905-4_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-19905-4_8

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-19904-7

  • Online ISBN: 978-3-319-19905-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation